Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma
Phase 2 Terminated
23 enrolled
A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Phase 1 Terminated
174 enrolled
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Phase NA Terminated
2,117 enrolled 6 charts
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Terminated
58,213 enrolled
QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Terminated
19 enrolled 22 charts
A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma
Phase 1 Terminated
11 enrolled
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
Phase 1 Terminated
189 enrolled
QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/2 Terminated
6 enrolled 10 charts
Heart Rate Variability, Vagus Nerve and Cancer
Phase NA Terminated
25 enrolled
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
Phase 1 Terminated
4 enrolled
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Phase 1 Terminated
27 enrolled
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma
Phase 1 Terminated
8 enrolled
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma
Phase 1 Terminated
6 enrolled 19 charts
Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients
Phase 1 Terminated
9 enrolled
A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma
Phase 1 Terminated
8 enrolled
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma
Phase 1 Terminated
41 enrolled 32 charts
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
Phase 2 Terminated
6 enrolled 8 charts
N1
Terminated
23 enrolled
Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer
Phase NA Terminated
11 enrolled 6 charts
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Phase 2 Terminated
12 enrolled 12 charts
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Phase 2 Terminated
17 enrolled 5 charts
A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)
Phase 1 Terminated
1 enrolled
BAY1238097, First in Man
Phase 1 Terminated
8 enrolled
Efficacy of a Patient Education Video
Phase NA Terminated
9 enrolled
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers
Phase NA Terminated
9 enrolled
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
Phase 1 Terminated
9 enrolled
Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
Phase 2 Terminated
6 enrolled 4 charts
Panobinostat/Velcade in Multiple Myeloma
Phase 1 Terminated
12 enrolled
SCRI Tissue Testing Registry
Terminated
20 enrolled
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
Phase 3 Terminated
151 enrolled 17 charts
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
Phase 1/2 Terminated
39 enrolled 9 charts
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
Phase 1 Terminated
75 enrolled